US2021106721A1PendingUtilityA1
Compositions comprising low molecular weight silk fibroin fragments and plasticizers
Est. expiryOct 31, 2036(~10.2 yrs left)· nominal 20-yr term from priority
C08L 5/08A61L 27/227C08K 5/0016A61L 27/56C08K 5/053C08L 89/00A61L 27/502A61L 27/26A61L 2400/06A61L 2430/34
75
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Various aspects described herein relate to compositions comprising silk fibroin fragments with particular characteristics and/or properties as well as methods of making and using the same.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A solution for forming a scaffold, the solution comprising silk fibroin fragments and glycerol, the silk fibroin fragments having a weight average molecular weight ranging from about 100 kDa to about 160 kDa, wherein the glycerol and the silk fibroin fragments are present in a weight ratio (glycerol to silk fibroin fragments) of about 1:100 to about 25:100; wherein the solution for forming the scaffold exhibits a glass transition temperature of equal to or less than about −15° C., and wherein the solution for forming the scaffold is sterile; and
wherein the solution for forming the scaffold, after sublimation, has a relative solubility in a range of about 1% to about 50%.
2 . The solution of claim 1 , wherein the glycerol and the silk fibroin fragments are present in a weight ratio of about 1:100 to about 8:100.
3 . The solution of claim 1 , wherein the solution further comprises an alcohol and/or a polyol.
4 . A silk fibroin particle comprising silk fibroin fragments and glycerol, wherein the silk fibroin fragments have a weight average molecular weight ranging from about 100 kDa to about 160 kDa, and wherein the silk fibroin particle comprises a porous structure characterized by interconnected pores having an average circle equivalent diameter of about 5 μm to about 60 μm and having an aspect ratio of about 1.0 to about 3.0,
wherein the silk fibroin particle has an aspect ratio of about 1 to about 3, and
wherein the glycerol and the silk fibroin fragments are present in a weight ratio (glycerol to silk fibroin fragments) of 1:100 to about 25:100.
5 . The silk fibroin particle of claim 4 , wherein the silk fibroin particle is formed from a lyophilized scaffold.
6 . The solution of claim 1 , wherein the solution has been sterilized by vacuum filtration.
7 . The solution of claim 1 , wherein the silk fibroin fragments have a weight average molecular weight ranging from about 130 kDa to about 160 kDa.
8 . The solution of claim 1 , wherein no more than about 5% of the total number of the silk fibroin fragments have a molecular weight of about 200 kDa or higher.
9 . The solution of claim 1 , wherein at least about 60% of the total number of silk fibroin fragments have a molecular weight of about 30 kDa to about 170 kDa.
10 . A silk fibroin scaffold formed from the solution of claim 1 .
11 . A silk fibroin particle formed from the scaffold of claim 10 .
12 . The silk fibroin particle of claim 4 , wherein the silk fibroin particle is formed from a sterile solution.
13 . The silk fibroin particle of claim 12 , wherein the sterile solution, after sublimation, has a relative solubility in a range of about 1% to about 50%.
14 . The silk fibroin particle of claim 12 , wherein the sterile solution has a glass transition temperature of equal to or less than about −15° C.
15 . The silk fibroin particle of claim 4 , wherein the glycerol and the silk fibroin fragments are present in the sterile solution at a weight ratio of 1:100 to about 8:100.
16 . The silk fibroin particle of claim 12 , wherein the sterile solution has been sterilized by vacuum filtration.
17 . The silk fibroin particle of claim 4 , wherein the silk fibroin fragments have a weight average molecular weight ranging from about 130 kDa to about 160 kDa.
18 . The silk fibroin particle of claim 4 , wherein the silk fibroin particle is formed from a sterile solution, wherein the sterile solution, after sublimation, has a relative solubility in a range of about 1% to about 50%, and wherein the sterile solution has a glass transition temperature of equal to or less than about −15° C.
19 . The silk fibroin particle of claim 18 , wherein the sterile solution has been sterilized by vacuum filtration.Join the waitlist — get patent alerts
Track US2021106721A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.